Introducing the BODi® Partner Podcast, the official podcast channel devoted exclusively to BODi Partners. From archives of the BODi Wake-Up Call, I Am BODi stories, and What I Know Now success tips from seasoned Partners, this podcast is your one-stop source for personal development, business training and peer-to-peer inspiration. Ready to explode your business? Tune in regularly to our official podcast and join the ranks of those transforming their lives and the lives of others!
…
continue reading
Konten disediakan oleh AgingYounger. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh AgingYounger atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !
Offline dengan aplikasi Player FM !
Why the Drug Companies won't Allow Disease Cures.
MP3•Beranda episode
Manage episode 185001229 series 1024467
Konten disediakan oleh AgingYounger. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh AgingYounger atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Disease of all types, especially cancer is BIG Business, for the Drug cartel. The cancer industry is spending virtually nothing of its multi-billion dollar resources on effective prevention strategies, such as dietary guidelines, exercise and obesity education. Instead, it pours its money into treating cancer, not preventing or curing it. Why would they shoot their cash cow? If they can keep the well-oiled Cancer Machine running, they will continue to make massive profits on chemotherapy drugs, radiotherapy, diagnostic procedures and surgeries. The typical cancer patient spends $50,000 fighting the disease. Chemotherapy drugs are among the most expensive of all treatments, many ranging from $3,000 to $7,000 for a one-month supply. If the cancer industry allows a cure, then their patient base goes away. It makes more sense to keep a steady stream of cancer patients alive, but sick and coming back for more-UNTIL they die. Tune in Wednesday at 7PM-est FOR THE REST OF THE STORY.
…
continue reading
301 episode
MP3•Beranda episode
Manage episode 185001229 series 1024467
Konten disediakan oleh AgingYounger. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh AgingYounger atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Disease of all types, especially cancer is BIG Business, for the Drug cartel. The cancer industry is spending virtually nothing of its multi-billion dollar resources on effective prevention strategies, such as dietary guidelines, exercise and obesity education. Instead, it pours its money into treating cancer, not preventing or curing it. Why would they shoot their cash cow? If they can keep the well-oiled Cancer Machine running, they will continue to make massive profits on chemotherapy drugs, radiotherapy, diagnostic procedures and surgeries. The typical cancer patient spends $50,000 fighting the disease. Chemotherapy drugs are among the most expensive of all treatments, many ranging from $3,000 to $7,000 for a one-month supply. If the cancer industry allows a cure, then their patient base goes away. It makes more sense to keep a steady stream of cancer patients alive, but sick and coming back for more-UNTIL they die. Tune in Wednesday at 7PM-est FOR THE REST OF THE STORY.
…
continue reading
301 episode
Усі епізоди
×Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.